Welcome to our dedicated page for Walgreens Boots Alliance news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreens Boots Alliance stock.
Walgreens Boots Alliance, Inc. (WBA) is the first global pharmacy-led, health and wellbeing enterprise. Formed in December 2014 through the combination of Walgreens and Alliance Boots, the company harnesses the strengths of two iconic brands with complementary geographic footprints and a heritage that dates back over a century. WBA operates over 13,100 stores in 11 countries and has a presence in more than 25 countries, employing over 370,000 people worldwide.
WBA is the largest retail pharmacy, health, and daily living destination in the USA and Europe, with its extensive network ensuring nearly three-quarters of Americans live within five miles of a Walgreens location. The company's revenue is majorly generated from prescription drug sales, which account for about two-thirds of its overall sales. Walgreens alone contributes to 20% of total prescription revenue in the U.S.
Alongside prescription sales, WBA's operations include retail products, European drug wholesale, and healthcare services. The company is continuously expanding its services with initiatives such as Health Corner and Village Medical, aiming to create an omnichannel experience for patients and positioning itself as a one-stop healthcare provider.
In recent developments, WBA has made significant strides towards sustainability, such as reducing single-use plastic in its packaging and collaborating with industry partners for better recycling practices. The efforts are part of the company's broader Environmental, Social, and Governance (ESG) initiatives aimed at reducing its environmental impact.
Additionally, Walgreens is expanding its specialty pharmacy services through the introduction of Walgreens Specialty Pharmacy, which integrates AllianceRx and focuses on providing care for patients with complex, chronic conditions. This initiative aims to improve patient outcomes and provide greater value to payers and partners.
WBA’s specialty pharmacy business is bolstered by its subsidiary, Shields Health Solutions, which supports health systems' specialty pharmacies across the U.S. Through these efforts, Walgreens continues to play a pivotal role in the healthcare system, offering comprehensive solutions that bridge gaps in patient care.
For National Women's Health Month, Walgreens has been highlighting the contributions of its female leaders, emphasizing the importance of women's health and wellness. The company organized events focused on work-life balance, mental health, and leadership development, furthering its commitment to diversity, equity, and inclusion.
With a mission to provide joy through better health, Walgreens Boots Alliance remains a trusted name in the healthcare and retail pharmacy sectors, continuously evolving to meet the needs of its customers and communities worldwide.
Walgreens Boots Alliance (Nasdaq: WBA) will announce its fiscal 2024 third-quarter results on June 27, 2024. The results will be released at 7 a.m. ET, followed by a conference call with WBA management at 8:30 a.m. ET.
The call will be simulcast on the WBA investor relations website and a replay will be available for 12 months.
Walgreens has announced a new wave of price reductions, extending their commitment to help customers save on over 1,300 products across various categories. This initiative follows similar efforts started in October 2023. Key price drops include Eucerin Advance Repair Hand Cream (now $5.99, down from $7.29) and Nice! Mini Pretzels (now $1.99, down from $2.79).
Additionally, Walgreens will reintroduce its myW Days promotional campaign in mid-July, offering personalized deals to its 110 million loyalty program members. These measures are designed to alleviate financial pressures on consumers and improve access to essential items.
Walgreens is launching its inaugural community health fair, “Walgreens en tu Comunidad,” in San Juan, Puerto Rico on June 8. The event aims to enhance access to health services and education, featuring health screenings, vaccinations, and various health-related activities. Key offerings include free HIV testing, blood pressure screenings, and routine immunizations. The fair will also provide CPR demonstrations and health education from the American Heart Association, prenatal vitamins from Vitamin Angels, and consultations from Walgreens beauty and wellness experts. Special guests include Puerto Rico senator Nitza Moran Trinidad and Walgreens' chief customer officer, Tracey Brown. The event will be held from 10 a.m. to 4 p.m. ET at the Walgreens store in Montehiedra.
Walgreens celebrated Clinical Trials Day with an event in Boston highlighting women's health in clinical trials and healthcare innovation. Kendal Whitlock, head of digital optimization for Walgreens Clinical Trials, emphasized raising awareness about gender-specific health disparities and the importance of women's participation in medical research. Keynote speakers, including Walgreens Chief Clinical Trials Officer Ramita Tandon and Dr. Yvette Cozier, shared insights on increasing women's involvement in clinical trials. Walgreens announced a new clinical trials center in Malden and highlighted milestones, such as reaching over 4 million potential trial participants with over 60% being women.
Walgreens Boots Alliance (WBA) has sold approximately $400 million worth of Cencora (COR) shares through a stock repurchase agreement, decreasing its ownership from 13% to 12%.
The proceeds will be used mainly for debt reduction and general corporate purposes, supporting WBA's strategy to enhance its health services rooted in retail pharmacy.
The sale does not affect the ongoing collaboration or long-term strategic partnership between the companies. Ornella Barra, COO International of WBA, will continue to serve on Cencora's Board of Directors.
Walgreens has announced the launch of its over-the-counter Walgreens Brand Naloxone HCl Nasal Spray, effective in reversing opioid overdoses.
Retailing at $34.99, it is a more affordable option compared to the national brand. Initially available online, it will be in all stores by the end of the month. This initiative aims to improve access to naloxone, potentially lowering the impact of the opioid epidemic in the U.S.
Dr. Priya Mammen, Senior Medical Director at Walgreens, emphasized the importance of this move in combating opioid overdoses. The product has received approval from the U.S. Food and Drug Administration.
Walgreens is honoring veterans, active-duty military personnel, and their families with a Memorial Day weekend discount from May 24 to May 27. Eligible customers with a myWalgreens® membership and valid military ID or proof of service will receive a 20% discount on regularly priced products at any Walgreens or Duane Reade stores nationwide. Exclusions apply, including alcohol, dairy, tobacco, and prescription items. The myWalgreens® membership is free and available at checkout. This initiative underscores Walgreens' commitment to supporting the military community.
Walgreens partners with Dion's Chicago Dream to address food insecurity in the Chicagoland area by providing fresh produce to over 275 households and 1,000 residents weekly for a year. The collaboration aims to improve health outcomes, create jobs, and promote health equity.
Walgreens is enhancing its specialty pharmacy services by introducing Walgreens Specialty Pharmacy, which includes Gene and Cell Services Pharmacy and Innovation Center. The company aims to improve patient outcomes, provide value to payers, and leverage its neighborhood pharmacies into growing healthcare areas. Walgreens Specialty Pharmacy offers a wide range of services, including gene and cell therapy, central specialty pharmacies, community-based specialty pharmacies, specialty-trained pharmacists, patient advocacy support, and distribution drugs. The company is focused on breaking through healthcare silos and providing comprehensive care to help payers manage specialty costs. With $24 billion in annual enterprise specialty revenue, Walgreens Specialty Pharmacy is the largest independent provider in the U.S. The company is committed to an integrated care model to serve patients effectively.
DoorDash and Walgreens have teamed up to offer SNAP customers the ability to make purchases at Walgreens using their SNAP/EBT cards. DoorDash is the first platform to enable SNAP customers to buy directly from Walgreens, expanding food access for millions of individuals living in food deserts or SNAP/EBT communities. This partnership provides convenient access to over 4,000 SNAP-eligible products for delivery within an hour through DoorDash, helping consumers fulfill their grocery needs quickly and affordably.
FAQ
What is the current stock price of Walgreens Boots Alliance (WBA)?
What is the market cap of Walgreens Boots Alliance (WBA)?
What is Walgreens Boots Alliance, Inc. (WBA)?
How many stores does Walgreens Boots Alliance operate?
What are the main revenue sources for Walgreens Boots Alliance?
What recent sustainability efforts has WBA made?
What is Walgreens Specialty Pharmacy?
How does Walgreens Boots Alliance contribute to women's health?
What role does Shields Health Solutions play within WBA?
How does Walgreens Boots Alliance ensure accessibility for its customers?
What is WBA's mission?
What recent expansions has WBA made in its core pharmacy business?
